Rosiglitazone reduces hepatic fat content

Rosiglitazone reduces hepatic fat content

書誌詳細
主要な著者:	Buckingham, R, Toseland, C, Draper, N, Clarke, K
フォーマット:	Journal article
出版事項:	2000

類似資料

Rosiglitazone prevents ischaemic injury in the obese Zucker rat heart
著者:: Sidell, R, 等
出版事項: (2001)

Leukemia and rosiglitazone
著者:: Irfan Yavasoglu, 等
出版事項: (2016-03-01)

Sirt1 and Sirt6 mediate beneficial effects of rosiglitazone on hepatic lipid accumulation.
著者:: Soo Jin Yang, 等
出版事項: (2014-01-01)

Rosiglitazone treatment improves cardiac efficiency in hearts from diabetic mice.
著者:: How, O, 等
出版事項: (2007)

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
著者:: Kahn, SE, 等
出版事項: (2006)

The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction.
著者:: Lygate, C, 等
出版事項: (2003)

Rosiglitazone-associated fractures in type 2 diabetes
著者:: Kahn, SE, 等
出版事項: (2008)

Possible modulation of the antidiabetic effect of rosiglitazone by buspirone
著者:: Wafaa R. Mohamed, 等
出版事項: (2012-06-01)

Incidence of diabetes following ramipril or rosiglitazone withdrawal
著者:: Holman, R, 等
出版事項: (2011)

Rosiglitazone reduces diabetes angiopathy by inhibiting mitochondrial dysfunction dependent on regulating HSP22 expression
著者:: Lingling Yu, 等
出版事項: (2023-04-01)

Guidance on rosiglitazone for type 2 diabetes mellitus.
著者:: Matthews, DR
出版事項: (2001)

Incidence of diabetes following ramipril or rosiglitazone withdrawal.
著者:: Investigators, D
出版事項: (2011)

Isolation, Synthesis and Characterization of Rosiglitazone Maleate Impurities
著者:: Singamsetty Radha Krishna, 等
出版事項: (2008-01-01)

Budget impact of rosiglitazone in type 2 diabetes
著者:: Orietta Zaniolo, 等
出版事項: (2007-03-01)

Safety and efficacy of rosiglitazone in the elderly diabetic patient
著者:: Adie Viljoen, 等
出版事項: (2009-04-01)

The autophagic regulation of rosiglitazone-promoted adipocyte browning
著者:: Yue Li, 等
出版事項: (2024-06-01)

Hepatic Angiomyolipoma with Minimal Intratumoral Fat Content
著者:: Masataka Banshodani, 等
出版事項: (2009-11-01)

Rosiglitazone , Metformin or both for Treatment of Polycystic Ovary Syndrome
著者:: Mohammed A.Taher, 等
出版事項: (2017-03-01)

Rosiglitazone , Metformin or both for Treatment of Polycystic Ovary Syndrome
著者:: Mohammed A.Taher, 等
出版事項: (2017-03-01)

Rosiglitazone and myocardial infarction in patients previously prescribed metformin.
著者:: Colin R Dormuth, 等
出版事項: (2009-06-01)

RP-HPLC Method for the Simultaneous Estimation of Rosiglitazone and Gliclazide in Tablets
著者:: G. Rathinavel, 等
出版事項: (2009-01-01)

Rosiglitazone ameliorates diffuse axonal injury by reducing loss of tau and up-regulating caveolin-1 expression
著者:: Yong-lin Zhao, 等
出版事項: (2016-01-01)

Effect of Rosiglitazone on Coronary Angiogenesis in Diabetic and Control Rats
著者:: Ensieh Salehi, 等
出版事項: (2011-06-01)

Rosiglitazone as an option for patients with acromegaly: a case series
著者:: Bahena-García Ana, 等
出版事項: (2011-05-01)

Simpson's paradox visualized: The example of the Rosiglitazone meta-analysis
著者:: Schumacher Martin, 等
出版事項: (2008-05-01)

The impact of acute rosiglitazone on insulin pharmacokinetics at the blood‐brain barrier
著者:: Demi C. Galindo, 等
出版事項: (2020-07-01)

High Concentrations of Rosiglitazone Reduce mRNA and Protein Levels of LRP1 in HepG2 Cells
著者:: Alejandro N. Rondón-Ortiz, 等
出版事項: (2017-11-01)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin.
著者:: Colin R. Dormuth, 等
出版事項: (2010-01-01)

Lipid metabolome-wide effects of the PPARγ agonist rosiglitazones⃞
著者:: Steven M. Watkins, 等
出版事項: (2002-11-01)

Preventive effects of Salvia officinalis leaf extract on insulin resistance and inflammation in a model of high fat diet-induced obesity in mice that responds to rosiglitazone
著者:: Mohamed R. Ben Khedher, 等
出版事項: (2018-01-01)

Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria
著者:: Rosauro Varo, 等
出版事項: (2017-05-01)

Co-Administration of Conjugated Linoleic Acid and Rosiglitazone Increases Atherogenic Co-Efficient and Alters Isoprenaline-Induced Vasodilatation in Rats Fed High Fat Diet
著者:: Chai, Boon Kheng, 等
出版事項: (2018)

Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats.
著者:: Soo Jin Yang, 等
出版事項: (2011-01-01)

Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet.
著者:: Vladimir Kus, 等
出版事項: (2011-01-01)

Protective effect of rosiglitazone on kidney function in high-fat challenged human-CRP transgenic mice: a possible role for adiponectin and miR-21?
著者:: Martine C. Morrison, 等
出版事項: (2017-06-01)

Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy.
著者:: Lachin, J, 等
出版事項: (2011)

Prenatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Adult Metabolic Phenotype
著者:: Hernan Sierra, 等
出版事項: (2012-01-01)

Correction: Rosiglitazone and Myocardial Infarction in Patients Previously Prescribed Metformin
出版事項: (2010-01-01)

Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes.
著者:: Zinman, B, 等
出版事項: (2010)

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.
著者:: Tan, G, 等
出版事項: (2005)